Boehringer Ingelheim to Mine Ginkgo’s Molecules in $406M Undruggable Targets Deal
Partnership seeks to identify novel therapeutic molecules to address diseases with high unmet patient needs. It’s the second target discovery company to link with BI in the last month.
